- Home
- AVDL vs DAVA Comparison
AVDL vs DAVA Comparison
Compare AVDL & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- DAVA
- Stock Information
- Founded
- AVDL 2015
- DAVA 2000
- Country
- AVDL Ireland
- DAVA United Kingdom
- Employees
- AVDL N/A
- DAVA N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- AVDL Health Care
- DAVA Technology
- Exchange
- AVDL Nasdaq
- DAVA Nasdaq
- Market Cap
- AVDL 1.4B
- DAVA 1.5B
- IPO Year
- AVDL 1996
- DAVA 2018
- Fundamental
- Price
- AVDL $11.66
- DAVA $28.69
- Analyst Decision
- AVDL Strong Buy
- DAVA Buy
- Analyst Count
- AVDL 6
- DAVA 12
- Target Price
- AVDL $24.00
- DAVA $40.09
- AVG Volume (30 Days)
- AVDL 1.7M
- DAVA 611.3K
- Earning Date
- AVDL 11-12-2024
- DAVA 11-12-2024
- Dividend Yield
- AVDL N/A
- DAVA N/A
- EPS Growth
- AVDL N/A
- DAVA N/A
- EPS
- AVDL N/A
- DAVA 0.16
- Revenue
- AVDL $138,160,000.00
- DAVA $1,001,724,970.00
- Revenue This Year
- AVDL $533.23
- DAVA $10.55
- Revenue Next Year
- AVDL $73.08
- DAVA $10.35
- P/E Ratio
- AVDL N/A
- DAVA $179.01
- Revenue Growth
- AVDL 1523.50
- DAVA N/A
- 52 Week Low
- AVDL $10.41
- DAVA $23.28
- 52 Week High
- AVDL $19.09
- DAVA $81.06
- Technical
- Relative Strength Index (RSI)
- AVDL 40.12
- DAVA 60.66
- Support Level
- AVDL $10.41
- DAVA $25.59
- Resistance Level
- AVDL $16.66
- DAVA $29.35
- Average True Range (ATR)
- AVDL 0.88
- DAVA 1.64
- MACD
- AVDL -0.31
- DAVA 0.24
- Stochastic Oscillator
- AVDL 20.00
- DAVA 52.65
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.